Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fragment-based Drug Discovery Market Snapshot
Chapter 4. Global Fragment-based Drug Discovery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Technology Advancement in Fragment-based Drug Discovery Market
4.8. Key Trends in the Market
Chapter 5. Market Segmentation 1: Type of Technique Estimates & Trend Analysis
5.1. Type of Technique & Market Share, 2020 & 2028
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Technique:
5.2.1. X-ray Crystallography
5.2.2. Nuclear Magnetic Resonance
5.2.3. Surface Plasmon Resonance
5.2.4. Other Screening Techniques
Chapter 6. Market Segmentation 1: Type of Service Estimates & Trend Analysis
6.1. Type of Service & Market Share, 2020 & 2028
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Service:
6.2.1. Library Screening
6.2.2. Fragment Screening
6.2.3. Fragment Optimization
Chapter 7. Fragment-based Drug Discovery Market Segmentation 2: End-Users Estimates & Trend Analysis
7.1. End-Users Analysis & Market Share, 2020 & 2028
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:
7.2.1. Industry Players
7.2.2. Non-industry Players
Chapter 8. Fragment-based Drug Discovery Market Segmentation 3: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Technique, 2020-2028
8.1.2. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Service, 2020-2028
8.1.3. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028
8.1.4. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2020-2028
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.2.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.2.3. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.2.4. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028
8.3.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.3.3. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028
8.3.4. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million)
8.4.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.4.3. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, (US$ Million)
8.4.4. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 2020-2028
8.5.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028
8.5.3. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028
8.5.3.1. South Africa
8.5.3.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 2bind
9.2.2. Charles River Laboratories
9.2.3. ChemAxon
9.2.4. ComInnex
9.2.5. ChemDiv
9.2.6. Creative Biolabs
9.2.7. Creative Biostructure
9.2.8. CRELUX
9.2.9. Domainex
9.2.10. Evotec
9.2.11. Red Glead Discovery
9.2.12. SARomics Biostructures
9.2.13. Shanghai ChemPartner
9.2.14. Sygnature Discovery
9.2.15. Vernalis
9.2.16. Other Prominent Player